NCT01725594View on ClinicalTrials.gov

A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003

PHASE1CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Dyslipidemia
Interventions
DRUG

CAT 2003

DRUG

Placebo

Trial Locations (1)

Unknown

Medpace CPU, Cincinnati

Sponsors
All Listed Sponsors
lead

Catabasis Pharmaceuticals

INDUSTRY

NCT01725594 - A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003 | Biotech Hunter | Biotech Hunter